Introduction
Although alteration of the ~53 tumor suppressor gene is the most frequent change in malignancy, the role played by loss of its function remains unclear (Donehower and Bradley, 1993) . In the prevailing view, wild-type ~53 acts as a "guardian of the genome" (Lane, 1992) ; in cells that sustain DNA damage, the p53 protein level rises and induces either Gl arrest or apoptosis, allowing DNA repair or eliminating the cells, whereas cells lacking p53 function accumulate mutations (Livingstone et al., 1992; Yin et al., 1992) . In this model, ~53 loss promotes tumorigenesis simply by facilitating the acquisition of oncogenic mutations. It may, however, have additional and possibly more direct roles. Wild-type p53 can mediate cell death (Oren, 1994) , and ~53 ablation may spare nascent neoplastic clones from apoptosis Symonds et al., 1994) .
The ~53 gene is also implicated in restriction of cell division potential. After a limited number of divisions (the Hayflick limit), normal cells subside into a senescent state (Hayflick and Moorhead, 1961) , whereas tumor cells are thought to be immortal. Tellingly, introducing a mutant ~53 gene facilitates establishment of permanent cell lines from primaryfibroblasts (Jenkinset al., 1984; Rovinski and Benchimol, 1988; Bond et al., 1994) , and spontaneously im- ' mortalized rodent fibroblasts often bear ~53 mutations (Harvey and Levine, 1991; Rittling and Denhardt, 1992) . A plausible role in senescence for wild-type ~53 is that it induces expression of the gene for a 21 kDa protein, prominent in senescent cells, that inhibits cell cycle-regulating protein kinases required for Gl progression (Harper et al., 1993; El-Deiry et al., 1993; Noda et al., 1994) . The notion that wild-type ~53 helps to impose the Hayflick limit is supported by evidence that cultured p53-'-mouse embryo cells yield fibroblast lines more readily (Livingstone et al., 1992; Harvey et al., 1993; Tsukada et al., 1993) , as do cells from patients with Li-Fraumeni syndrome (Bischaff et al., 1990) . It remains controversial, however, whether ~53 inactivation suffices for immortalization and whether its loss acts directly (Bond et al., 1994; Tsukada et al., 1993; Lowe et al., 1994) or merely by allowing other mutations (Harvey et al., 1993) .
A deeper understanding of the role of ~53 loss requires clonal analysis in cell systems having well-defined differentiation. Evidence on its role in proliferation of nonfibroblastic cells remains limited (Tsukada et al., 1993; Lotem and Sachs, 1993) . We have focused on the well-characterized transformation of erythroid precursors (reviewed by Metz, 1994) . While normal erythroid progenitors require growth factors such as erythropoietin and soon differentiate into postmitotic erythrocytes, leukemogenic retroviruses encoding a kinase oncoprotein such as v-ErbB or v-Raf allow the cells to grow without added factor, providing a colony assay for transformation (Graf et al., 1981; Klinken et al., 1988) . Viruses that also encode a nuclear oncoprotein, such as v-ErbA (Graf and Beug, 1983) or Myc (Blasi et al., 1985) , further enhance self-renewal of the progenitors (Klinken et al., 1989) .
Although the initial transformation of avian and murine erythroid cells appears equivalent, their subsequent proliferative potential differs greatly. Transformed clones of chicken cells can undergo >40 population doublings (Graf and Beug, 1983) , whereas murine clones cannot expand (Waneck and Rosenberg, 1981; Anderson et al., 1985; Klinken et al., 1988; Miller et al., 1990) . This dichotomy may reflect the shorter endowed longevity of murine cells: 8-20 doublings (Rohme, 1981; Harvey et al., 1993) , compared with 30-50 for the chicken (Beug and Graf, 1977) . Since a typical macroscopic colony of lo4 cells has accrued >13 divisions, the murine colonies may have reached their Hayflick limit. Breaching this barrier probably requires mutation. The rare mouse erythroid lines arising from mass cultures infected with the myc-raf or myc virus are clonal (Klinken et al., 1988; Cory et al., 1991) , indicative of genetic alteration.
If an intrinsic senescence program limits the proliferation of erythroid cells, wild-type ~53 could be instrumental, because most mouse erythroid cell lines, which derive from erythroleukemias induced by the Friend retrovirus, bear ~53 alterations (Lane and Benchimol, 1990) , as do all permanent avian erythroid lines (Ulrich et al., 1992 ).
Hence, we tested whether the absence of ~53 would facilitate generation of mouse hematopoietic cell lines by oncogenie retroviruses. We found that the absence of ~53 allowed virtually all clones induced by a myc-raf virus to expand indefinitely and readily provoke tumors. Thus, ablation of p53 together with activation of these oncogenes suffices for immortalization of hematopoietic cells. These findings establish that ~53 loss can contribute directly to tumorigenesis. Characterization of the lines also provided suggestive evidence of a checkpoint role for wild-type ~53 late in the mitotic cycle.
Results
Absence of ~53 Does Not Influence Transformation or Erythroid Differentiation To determine whether transformation was affected by ~53 status, we infected fetal liver cells from p53-'-or wild-type mice, plated them in semisolid medium, and monitored them for colony formation (Klinken, 1988) . The replicationincompetent viruses tested express the myc plus raf oncogenes, either gene alone, or simply a neo gene. Only the raf and the myc-raf viruses provoked colony formation (Table 1) . Importantly, the absence of ~53 did not affect the number of colonies obtained in several such experiments, and it only enhanced colony size by -50% (Table l) , representing less than one extra cell division. Thus, transformation per se was not influenced by the ~53 gene.
Irrespective of ~53 status, all raf virus-transformed colonies and 85% of those generated with the myc-raf virus proved to be erythroid (see below). The v-raftransformants were dominated by mature cells; most cells were small (7-10 pm diameter), and an average of 60% stained with benzidine. By contrast, typical myc-raf erythroid colonies comprised blast-like cells of 1 O-15 urn, and only 30% expressed hemoglobin. Hence, the erythroid colonies generated by myc-raf are less mature than the fef transformants. Significantly, ~53 genotype did not affect the proportion of benzidine-positive cells obtained with either virus. Thus, erythroid differentiation does not seem to be influenced by ~53.
Absence of ~53 Favors Indefinite Expansion
Of my&f8f-TI'SItSfOmWd ClOneS
Although colony development was unaffected by ~53 status, the absence of p53 greatly enhanced their subsequent expansion in liquid culture (Figure 1 ). While not one of 103 wild-type raf colonies proliferated significantly, 18% of the p53-I-rafclones expanded beyond 10scells. Similarly, whereas <lo% of wild-type myc-raf colonies could be propagated, virtually every p53-'-myc-faf clone (98%) whether erythroid or nonerythroid, readily expanded. Hence, the absence of ~53 markedly augmented clonal longevity.
After a few days in liquid culture, the ~53' myc-raf clones appeared distinct from those of other genotypes. Microscopically, their cultures were uniformly healthy, whereas the others comprised dying populations, from which rare subclones sometimes emerged (data not shown). This dichotomy in growth pattern was also evident from clonal analysis of viability ( Figure 2A ) and the kinetics of expansion (Figures 28 and 2C) . The p53-/-myc-raf clones, whether erythroid or nonerythroid, expanded continuously without a crisis ( Figure 2B ), a delay occurring only in the few dominated by mature (smalt, hemoglobinpositive) cells. The typical clones doubled every 10 hr (Figure 2C) . By contrast, with every other genotype, viability began to fall after only 3 days; all wild-type raf clones were extinguished within 1 week, and most wild-type myc-raf and p53-'-raf cultures within 3 weeks ( factor, or interleukin-3. Thus, as observed by Klinken et al. (1988) clonal longevity did not appear to be dependent on these growth factors.
To determine whether expanded colonies could yield permanent lines, we monitored representative clones on prolonged culture. We cultivated 15 p53-'-myc-raf clones (ten erythroid and five nonerythroid), eight p53-'-raf erythroid clones, and three wild-type myc-faf nonerythroid clones from 2 months to >6 months, representing from 100 to >300 doublings. Not a single clone senesced or was lost. Thus, cell lines arise consistently from expandable colonies.
High Proportion of Immortal Cells in p53+ myc-raf Colonies
If the absence of p53 directly eliminated a barrier to indefinite proliferation rather than merely allowing "immortaliz- The plating efffciency (number of secondary colonies per 100 cells seeded) was determined 6 days later. Each symbol shows the plating efficiency of an individual primary colony, and the type of symbol indicates either the average size of secondary colonies or the absence of growth. Clusters were defined as aggregates containing up to 500 cells. Symbols below the broken line represent replating efficiencies of <O.l%.
ing" mutations to develop, a high proportion of cells in each primary colony should be immortal. We tested this hypothesis by secondary colony assays (Figure 3) . The p53-'-myc-ref colonies proved to be highly clonogenic. All of 22 erythroid clones that proliferated well in parallel liquid cultures replated with efficiencies from 5% to S&It% (mean, 29%) values as high as with well-established lines. Moreover, all of 25 secondary colonies tested yielded large tertiary colonies at high efficiency (>lO%), while another 50 all expanded rapidly in liquid culture. Nonerythroid p53-'-myc-raf colonies behaved similarly (data not shown). Thus, a substantial proportion of cells in each primary p53-'-myc-raf colony can proliferate indefinitely, favoring a direct role for ~53 loss in immortalization (see Discussion). By contrast, erythroid colonies of the other three genotypes exhibited minimal clonogenicity (Figure 3) . Nearly all resulting colonies contained <200 cells, and even the rare secondary colonies possessing up to 5 x 103 cells did not expand in liquid culture or initiate tertiary colonies. Hence, the transformed clones of these genotypes ap peared to have exhausted their growth potential.
All these data suggest that prolonged expansion of wildtype myc-ref and p53-I-raf colonies requires additional genetic changes, while activated myc and raf oncogenes in a p53+ context are sufficient for immortalization. gens confirmed that erythroid lines predominated. Most of these contained some ceils bearing the erythroid marker Ter-119, while none expressed myelomonocytic markers (F4/80, Mac-l, or Gr-1). Interestingly, the receptor for stem cell factor, c-Kit, was expressed in most p53-'-raf lines, but in only one of 13 myc-raf erythroid lines generated from either p!W-or wild-type cells. This finding may indicate that the raf and myc-raf viruses preferentially transform different erythroid progenitors or that up-regulation of c-Kit favors establishment of the raf transformants.
The erythroid lines remained able to differentiate. Erythropoietin increased the proportion of benzidine-positive cells by 2-to 40-fold in all of 24 erythroid p53-'-myc-raf lines and all of seven p53-'-raf lines tested. Hence, the absence of p53 does not interfere with erythropoietininduced differentiation.
The majority of nonerythroid myc-raf transformants were clearly myelomonocytic.
They expressed F4/80 and Mac-l, and some displayed Gr-1, Thy-l (which is often found on primitive myelomonocytic cells), or both. Several other lines, however, lacked all markers tested and probably represent hematopoietic progenitors. of these lines, two differentiated spontaneously into macrophages and must represent myeloid precursors.
Early Passage p53-I-myc-raf Cells Are Tumorigenic Do genetic changes that allow immortalization suffice for tumorigenesis?
Leukemia developed within a few weeks in mice injected intravenously with seven established cell lines. However, because mutation may accompany establishment of lines, transplantation tests were performed on freshly isolated p53-'-myc-raf colonies as soon as sufficient cells accumulated. After only 6-10 days in liquid culture, four erythroid clones were injected intravenously. By 3-8 weeks later, every recipient had developed erythroleukemia. Ten other new clones (five erythroid and five nonerythroid) yielded tumors within 3 weeks. The tumors clearly derived from the transplanted cells, because reestablished cell lines yielded polymerase chain reaction products specific for the p53-'-mice. Hence, activation of the myc and raf oncogenes plus inactivation of p53 may be sufficient to render mouse hematopoietic cells fully tumorigenic.
~53~'~ Cell Lines Can Remain Diploid, Even after Growth as a Tumor Since fibroblasts lacking p53 display karyotypic instability (Harveyet al., 1993; Tsukada et al., 1993) we enumerated the chromosomes in our p53-I-erythroid cell lines. Significantly, even after 3-4 weeks in liquid culture (30-40 population doublings), all ten p53-'-myc-raf lines analyzed retained a diploid karyotype; i.e., the vast majority of cells contained 40 chromosomes (e.g., Figure 4A ) and exhibited no marker chromosome. Moreover, of eight raf lines examined, five were diploid and three aneuploid. Thus, aneuploidy is not necessary for immortalization.
To investigate karyotypic stability during tumorigenesis, we transplanted diploid p53-'-myc-raf cell lines into mice and analyzed the karyotype of cell lines grown from the resulting tumors. Of eight lines, three remained diploid (e.g., Figure 4B ), and four of the remaining five were near diploid; i.e., a substantial proportion of cells retained 40 chromosomes ( Figure 4C ). Only one of the eight tumor lines was aneuploid, with 39 chromosomes most prevalent. None of these lines displayed highly variable numbers of chromosomes in individual cells, although instability was occasionally observed in lines cultured for >2 months, representing >150 doublings ( Figure 4D ). Thus, ~53 loss does not directly impose karyotypic instability.
Multinucleate
Cells in Lines Lacking ~53 Many of the p53-'-lines contained a small subpopulation of abnormally large multinucleate cells, with a diameter of 940 pm ( Figure 5A ). Their presence correlated with the metaphase spreads exhibiting multiples of the normal chromosome set ( Figure 5B ), occasionally reaching >lOOO chromosomes. The giant cells were not observed in freshly isolated myc-raf clones from wild-type cells but were found in most, if not all, erythroid p53-'-myc-raf clones, even at early passage; in some marker-negative p53-'- myc-raf lines; and in many postcrisis p!Q-'-raf clones. Hence, their presence appeared to correlate with the absence of the p53 gene. Although giant cells usually comprised <l% of a culture, erythropoietin-treated clones and cultures recently initiated from cryopreserved clones contained many more, in extreme cases up to 50% of the cells ( Figure 5C ). A potential relationship to megakaryocytes, a polyploid cell type sometimes found in predominantly erythroid lines, was ruled out by the consistent failure of the giant cells to stain for acetylcholinesterase.
Instead, most of those in erythroid lines stained strongly with benzidine ( Figure 5C ), identifying them as erythroid. These findings may indicate that loss of ~53 impairs the control of cytokinesis (see below).
Discussion
Breaking the Barriers to Indefinite Proliferation The most striking finding of this study was that the absence of ~53 allowed the efficient immortalization of hematopoietic cells. Virtually every colony of ~53~'~ cells induced by infection with a myc-raf retrovirus readily expanded in liquid culture (Figures 1 and 2) . Viability remained uniformly high, and a substantial proportion of cells in each primary colony could propagate the line (Figure 3) . Clones appeared able to proliferate indefinitely, doubling every 10 hr, without evidence of crisis or a senescent phase. We conclude that the myc-raf combination renders ~53~'~ cells immortal.
By contrast, derivation of lines from wild-type cells carrying myc and raf or of p53-'-clones containing only the raf oncogene almost certainly required mutation. Extensive cell death preceded the sporadic expansion of clones, and high clonogenicity appeared only after establishment. From the proportion of these clones that did expand, we infer that only 1 in 105 transformed cells could produce a line. Thus, loss of ~53 greatly facilitates immortalization but does not suffice.
The need for several genetic changes to immortalize cells undoubtedly reflects the multiple barriers that normally constrain indefinite proliferation. As illustrated in Figure 6 , three major impediments are dependence on growth factors for both proliferation and survival, the inbuilt program of terminal differentiation characteristic of each cell lineage, and, perhaps the ultimate defense, the Hayflick limit thought to hold for most cells within an organism. It seems instructive to consider in turn how the oncogenes and ablation of ~53 help to overcome these barriers.
Because Raf and Myc lie on separate signal transduction pathways emanating from many growth factor receptors, both are likely to contribute to relief of growth factor requirements. For erythroid progenitors, Raf must allow limited autonomous growth, since erythroid colonies arise with v-raf alone (Klinken, 1966; see Table 1 ). Because their liquid cultures soon perished, however, v-Raf alone probably provokes (or allows) normal terminal erythroid maturation or gives an unbalanced mitogenic signal that triggers apoptosis. The oncogenic synergy between Myc and Raf (Blasi et al., 1985; Principato et al., 1990) , like that of Myc and Ras, may reflect a need for two complementary mitogenic signals to achieve autonomy. Myc can also impede maturation, including that of erythroid cells (Coppola and Cole, 1986) , perhaps by hastening their passage through a Gl state from which differentiation normally ensues. That Myc increased self-renewal of the progenitor cells at the expense of terminal differentiation is supported by the less mature phenotype of the myc-raf clones than the raf-only ones, regardless of the presence of ~53, and by the much higher proportion of clonogenic cells in the myc-raf transformants (Figure 3) . Thus, Myc plus Raf may render the cells autonomous and hinder their normal terminal differentiation, circumventing the first two barriers (Figure 6 ).
What role did the absence of ~53 play? Did it simply prevent the exit from the cell cycle that attends terminal erythroid differentiation? That might hold for the faf transformants but seems very unlikely for the myc-raf ones because the typical etythroid and many nonerythroid clones were immature. Did it merely prevent cell death provoked by deficient culture conditions? Such effects cannot be completely discounted, but infected primary p53-'-cells did not yield more colonies or substantially larger ones (Table l) , and liquid cultures supplemented with factors that favor survival of erythroid cells did not allow wild-type clones to expand. Did absence of ~53 spare the cells from some tendency to apoptosis engendered by Myc plus Raf? Reduced apoptosis has been proposed to explain the increased frequency with which ~53" fibroblasts are immortalized by the adenovirus El A gene . On this hypothesis, however, the absence of ~53 should have enhanced the initial production of colonies by the myc-raf virus. No such effect was found (Table 1) .
~53 as an Enforcer of Senescence Because enhanced clonal longevity was the major consequence of p53 loss observed here, we suggest that ~53 ablation opensa third barrier, distinct from lineage-specific terminal differentiation. This may represent an intrinsic senescence program that ensures the eventual loss of proliferative capacity by normal somatic cells (Figure 6) . A general role for wild-type ~53 in enforcing a Hayflick limit on any given cell type would explain why p53-'-cells of hematopoietic and fibroblastic lineages are both rendered susceptible to immortalization, even though wild-type ~53 can inducedifferent fates, apoptosis in hematopoieticcells and growth arrest in fibroblasts. It would also provide a clear parallel with avian studies, in which it has been shown that the rare clones that proliferate indefinitely have all suffered ~53 lesions (Ulrich et al., 1992) . In this model, growth of our p53-'-raf clones is constrained by normal terminal differentiation, while wild-type myc-raf clones encounter the Hayflick limit. However, other models for restricted growth, such as a requirement for unidentified growth factors, cannot as yet be ruled out.
Does the absence of ~53 function directly augment clonal longevity or merely allow outgrowth of cells sustaining mutation, e.g., in a senescence gene? Our results strongly favor a direct role. The high replating efficiency in nearly every colony of p53+ myc-raf cells (Figure 3) would demand mutation within the first few cell divisions, i.e., a rate vastly exceeding known mutation rates (Holliday, 1969) . A direct role is also favored by the diploid karyotype retained by the p53-'-myc-raf lines for >30 population doublings ( Figure 4A ). Thus, wild-type ~53 may be an important component of the trigger for senescence. In fibroblasts, ~53 is likely to act via induction of the p21 inhibitor of cyclindependent kinases operative in the Gl phase (Noda et al., 1994; Harper et al., 1993; El-Deiry et al., 1993) but the mechanism by which it induces apoptosis in hematopoietic cells is less well understood (Oren, 1994) . lmmortallzation as a
Step Toward Tumorigenesls Our results suggest that overcoming senescence may contribute substantially to tumor development. The immortal clones of p53+ myc-raf cells appeared to be tumorigenic from their inception. Consistent with the possibility that these three genetic alterations render an immature hematopoietic cell fully malignant, some cell lines recovered from the tumors remained diploid (Figure 58 ). Since not all tumors arose synchronously, however, and a few had an altered karyotype, growth in the animal may sometimes select a more malignant subclone.
A plausible model for cellular senescence is that cell divisions are "counted" by gradual attrition of telomeres of chromosomes (de Lange, 1994 ) until a threshold length triggers p53-induced arrest or apoptosis. At least for human cells, extensive propagation beyond this barrier may require reactivation of telomerase activity. The presence of telomerase in >90% of primary human tumors and virtually all cell lines, but not in normal human somatic tissues, underlines the importance for tumorigenesis of overcoming senescence (Kim et al., 1994) . Hence, bypassing senescence may be the major contribution of ~53 alteration to tumor development.
It probably also contributes by sanctioning persistence of cells sustaining DNA damage (see Introduction), allowing proliferation under suboptimal conditions (Harvey et al., 1993) and sparing from apoptosis cells bearing oncogenic changes Symonds et al., 1994) . The multiplicity of checkpoints under surveillance by ~53 may account for its frequent alteration at either early or late stages of tumorigenesis.
A Potential Mitotic Checkpoint Role for p53 A distinctive checkpoint role for wild-type ~53 may account for our detection of multinucleate cells in p53-'-lines (Figure 5) . Possible precedents are that some p53-'-animals develop giant multinucleated spermatocytes (Rotter et al., 1993 ) that many early-passage p53-'-fibroblasts are hyperdiploid (Harvey et al., 1993) and that the pancreas of ~53~'~ mice contains some cells with a tetraploid DNA content (Cross et al., 1995) . Hence, in addition to its Gl checkpoint role(s) (Donehower and Bradley, 1993) wildtype ~53 may help to monitor mitosis and meiosis, perhaps forming part of a checkpoint designed to stop cells from reentering the cell cycle before completing cytokinesis or to kill those that do. The system monitored might be the mitotic spindle (Cross et al., 1995) or completion of cytokinesis.
Facile Generation of Differentiating Cell Lines Evidence that overexpression of wild-type ~53 can provoke terminal differentiation has suggested a role in control of maturation (Prokocimer and Rotter, 1994) . In our work, however, ~53 status had no effect on erythroid differentiation, nor was any observed in avian cells (Ulrich et al., 1992) . In view of recent evidence (reviewed by D'Andrea, 1994) that terminal erythropoiesis proceeds via extension of the Gl phase, transient Gl delay triggered by ~53 overexpression may force maturation, even though the normal pathway usually bypasses ~53.
Our observation that the absence of ~53 does not perturb cellular phenotype or differentiation capacity makes p53-'-mice a particularly attractive source for novel cell lines. With p53-'-fetal liver cells, the myc-raf virus readily yielded lines of erythroid and myelomonocytic cells as well as a putative myeloid progenitor, and lymphoid cells almost certainly would also be obtained with an appropriate culture medium. Hence, it should be feasible to derive factor-independent cell lines representative of most hematopoietic lineages and maturation stages, perhaps including rare cell types such as the stem cell. Diverse nonhematopoietic cells should also be accessible.
Experlmental Procedures
Retroviruses, Infection of Fetal Liver Cells, arid Colony Assays All viruses were produced in helper-free form using Y2 packaging cell lines provided by Dr. S. Gory. The myc-raf virus was J2 (Rapp et al., 1963 ) the raf virus (encoding v-raf) was 3611 murine sarcoma virus (Rapp et al., 1963 ) the myc virus (carrying the mouse c-myc gene) was MPZen(myc) (Gory et al., 1991) and the neo control virus was ZipNeo (Cepko et al., 1964) .
Fetal livers were pooled from day 12 or day 13 wild-type or p53*/' embryos (Livingstone et al., 1992) . The ~53.'. embryos, identified by PCR analysis (Livingstone et al., lQQ2) , came from matings between ~53~'. parents containing on average 90% C57BL/6,7% SJL, and 3% 129 alleles. (Mice with a simpler genotype were not available because of a low yield of p5b'-females from matings of >QQ% C57BU6 mice.) The wild-type embryos were progeny of (C57BU6 x SJL)Fl females and C57BU6 males.
For retroviral infection, typically 7.5 x IO fetal liver cells were cultivated on a layer of irradiated (26 Gy) virus-producing Y2 cells in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal calf serum and 1000 U/ml interleukin-3, supplied as conditioned medium from the cell line X63Ag6-653mlL-3 (Karasuyama and Melchers, 1966) . After 2 days, the nonadherent ceils were replated in a new dish for 2 hr to deplete any contaminating adherent cells and then seeded at several densities (2 x 16 to 5 x IO' cells per 36 mm dish) in 1 ml of semisolid Iscove's modified Dulbecco's medium (IMDM) containing 1.44% methylcellulose (Fluka), 20% fetal calf serum, and 0.1 U/ml human recombinant erythropoietin. IMDM plus 20% fetal calf serum was used routinely, because pilot experiments showed it to be superior to the more commonly used DMEM plus 10% fetal calf serum for maintenance of etythroid clones. Large macroscopic'colonies were scored and picked on day 6 or 7. To determine their average cell content, 20 successive colonies were pooled and the cells counted in a hemocytometer. Secondary colony assays used the same conditions as the primary assays; 5 x 102 to 10' cells were seeded in 1 ml of semisolid medium in a 36 mm dish. Plating efficiency was not affected by the number of plated cells. Cultures were kept at 5 x 105 to 2 x IO6 cells per milliliter by daily partial medium exchange.
Cytocentrifuged cells were stained with modified Wright's stain (DiffQuick, Lab-Aids) or with May-Griinwald-Giemsa stain (Metcalf, 1964) or for acetylcholinesterase (Karnovsky and Roots, 1964) . Hemoglobin was detected in cell suspensions with benzidine (Cooper et al., 1974) . To assess responsiveness to erythropoietin, we grew subcultures for 3 days in the presence or absence of 4 U/ml human recombinant erythropoietin and determined the proportion of benzidine-positive cells.
To detect surface antigens, cells were stained with monoclonal antibodies and analyzed by flow cytometry as described previously (Strasser et al., 1991 Chromosome Enumeration Cells cultured for 2-2.5 hr in 1 pM colchicine were allowed to swell for 10 min in 0.56% (w/v) KCI in water and then were fixed in methanol/ acetic acid, air dried on a microscope slide, and stained with Giemsa.
